Literature DB >> 19641515

Significance of the S100A4 protein in psoriasis.

John R Zibert1, Lone Skov, Jacob P Thyssen, Grete K Jacobsen, Mariam Grigorian.   

Abstract

The S100A4 protein is reported as a pivotal player in the tumor microenvironment with a metastasis-promoting function. Moreover, the upregulation of S100A4 is found in other non-malignant human disorders as cardiac and pulmonary systems and rheumatoid arthritis. In this study, we investigated the expression and significance of S100A4 in psoriasis. We found significant upregulation of S100A4 in the dermis of psoriatic skin compared with normal skin. This pattern of S100A4 expression differs considerably from that of other S100 proteins, S100A7 and S100A8/9, with predominant expression in the epidermis of psoriasis. Furthermore, we revealed a massive release of the biologically active forms of S100A4 from psoriatic skin. Interestingly, we found stabilization (increase) of p53 in the basal layer of epidermis in close proximity to cells expressing S100A4. To examine the possible implication of S100A4 in the pathogenesis of psoriasis, we analyzed the effect of S100A4 blocking antibodies in a human psoriasis xenograft SCID mouse model and observed a significant reduction of the epidermal thickness and impairment in cell proliferation and dermal vascularization. In conclusion, we showed strong upregulation and release of S100A4 in the upper dermis of psoriatic skin and found evidence indicating that S100A4 might actively contribute to the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19641515     DOI: 10.1038/jid.2009.206

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.

Authors:  Barbora Šumová; Lucie Andrés Cerezo; Lenka Szczuková; Lucie Nekvindová; Michal Uher; Hana Hulejová; Radka Moravcová; Mariam Grigorian; Karel Pavelka; Jiří Vencovský; Ladislav Šenolt; Jakub Závada
Journal:  Rheumatol Int       Date:  2018-11-03       Impact factor: 2.631

2.  Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis.

Authors:  Helia B Schonthaler; Reto Huggenberger; Stefanie K Wculek; Michael Detmar; Erwin F Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

3.  Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice.

Authors:  Birgitte Forst; Matilde Thye Hansen; Jörg Klingelhöfer; Henrik Devitt Møller; Gitte Helle Nielsen; Birgitte Grum-Schwensen; Noona Ambartsumian; Eugene Lukanidin; Mariam Grigorian
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

4.  Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice.

Authors:  Qun Li; Fang Ke; Weiwei Zhang; Xiaoyan Shen; Qiannan Xu; Hong Wang; Xue-Zhong Yu; Qibin Leng; Honglin Wang
Journal:  PLoS One       Date:  2011-02-02       Impact factor: 3.240

5.  The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies.

Authors:  Lenka Pleštilová; Heřman Mann; Lucie Andrés Cerezo; Ondřej Pecha; Jiří Vencovský; Ladislav Šenolt
Journal:  Arthritis Res Ther       Date:  2014-10-31       Impact factor: 5.156

Review 6.  Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies.

Authors:  Fei Fei; Jie Qu; Chunyuan Li; Xinlu Wang; Yuwei Li; Shiwu Zhang
Journal:  Cell Biosci       Date:  2017-11-25       Impact factor: 7.133

7.  S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity.

Authors:  Barbora Šumová; Lucie Andrés Cerezo; Hana Hulejová; Klára Prajzlerová; Michal Tomčík; Kristýna Bubová; Jan Štěpán; Mária Filková; Tereza Kropáčková; Mariam Grigorian; Karel Pavelka; Jiří Vencovský; Ladislav Šenolt
Journal:  BMC Rheumatol       Date:  2020-01-31

Review 8.  Multifunctional Role of S100 Protein Family in the Immune System: An Update.

Authors:  Parul Singh; Syed Azmal Ali
Journal:  Cells       Date:  2022-07-23       Impact factor: 7.666

9.  Pharmacological Inhibition of S100A4 Attenuates Fibroblast Activation and Renal Fibrosis.

Authors:  Jia Wen; Baihai Jiao; Melanie Tran; Yanlin Wang
Journal:  Cells       Date:  2022-09-05       Impact factor: 7.666

Review 10.  S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases.

Authors:  Katarzyna Kurpet; Grażyna Chwatko
Journal:  Molecules       Date:  2022-10-06       Impact factor: 4.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.